Indian-Share-Tips.Com

ISO 9001:2008 Certified

We are SEBI Registered Investment Advisory Serivces. Speak to us to Know More...

Daily One Hot Intraday Tip in Equity to Get You Profit by 11 AM EveryDay.

Know More

Trade Intraday in Future to Quadruple Your Earnings & Finish Before 11 AM Everyday.

Know More

Daily One Option in Intraday is the Order of the Day to Earn Extra Income before 11 AM.

Know More

Is Procter & Gamble Health Ltd. (BSE: 500126) a Strong Buy After Its Breakout?

Is Procter & Gamble Health Ltd. (BSE: 500126) a Strong Buy After Its Breakout?

About Procter & Gamble Health Ltd.

Procter & Gamble Health Ltd. is a leading player in India's pharmaceutical and healthcare sector, known for its trusted brands and strong parentage from Procter & Gamble. The company focuses on vitamins, minerals, and supplements, catering to both prescription and consumer healthcare segments.

Key Highlights

  • Breakout above falling trend channel signals potential trend reversal.
  • Strong upward momentum post-breakout.
  • Positive moving average crossover supports bullish outlook.
  • Support level identified near ₹5,000.
  • Resistance zone around ₹6,570.
  • Positive volume trend indicates accumulation by investors.
  • Medium to long-term outlook remains positive, though long-term confirmation is pending.

Peer Comparison

Company Market Cap P/E Ratio ROE
Procter & Gamble Health Ltd. ₹8,500 Cr 45x 22%
Abbott India Ltd. ₹55,000 Cr 48x 30%
GlaxoSmithKline Pharma ₹28,000 Cr 42x 25%

SWOT Analysis

Strengths

  • Strong brand equity
  • Consistent financial performance
  • Global parent backing

Weaknesses

  • High valuation multiples
  • Limited product diversification

Opportunities

  • Growing healthcare awareness
  • Expansion in nutraceuticals

Threats

  • Regulatory risks
  • Intense competition

Valuation & Investment View

The stock has shown a strong technical breakout supported by volume accumulation and moving average signals. While valuations remain on the higher side, the company's consistent performance and brand strength justify a premium. Investors may consider accumulating on dips near ₹5,000 with a medium to long-term perspective, keeping an eye on resistance near ₹6,570.

Investor Takeaway

According to Derivative Pro & Nifty Expert Gulshan Khera, CFP®, Procter & Gamble Health Ltd. presents a technically positive setup with improving momentum. However, investors should wait for long-term trend confirmation before aggressive allocation.

Related Queries

  • Is Procter & Gamble Health a good long-term investment?
  • What is the target price for P&G Health stock?
  • Should I buy P&G Health after breakout?
  • What are the support and resistance levels for P&G Health?

Disclaimer

This article is for educational purposes only and does not constitute investment advice. Please consult your financial advisor before making any investment decisions. Investments in securities are subject to market risks. Read all related documents carefully before investing.

tags: Procter & Gamble Health, BSE 500126, stock analysis India, pharma stocks India, breakout stocks, Gulshan Khera, Indian Share Tips

Send Your Message to Get a Quick Reply in Email or Phone Call


SEBI Regd Investment Advisor Regn no INA100011988

Get a Quick Reply or Call from us

Click Here